Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neuroendocrine Tumors, WHO Grade I-II × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Thyroid Nodule 2 Thyroid Neoplasms 1 Recurrence 1 Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1 Neuroma 1 Neuralgia 1 Liver Metastasis Colon Cancer 1 Klatskin Tumor 1 Kidney Neoplasms 1 Hypesthesia 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Bone Cancer Metastatic 1 Bile Duct Neoplasms 1 Agnosia 1 Adrenocortical Adenoma 1 Adenoma, Islet Cell 1

Interventions

Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05243082 2023-03-30

ERFA-PNET

Oslo University Hospital

Phase NA Recruiting

EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors, WHO Grade I-II

Data powered by HemOnc (CC BY 4.0) Colophon ⚡